-transparent.png){kind=logo}
Human lymphoblastoid interferon from Namalwa cells was purified for clinical use by ethanol fractionation, and used as adjuvant of an inactivated Bovid Herpesvirus 1 vaccine in calves. In agreement with other in vitro and in vivo models, low and high interferon doses were shown to increase and depress the specific antibody response, respectively. The low, effective interferon dose (100 International Units/kg) also reduced the variability of antibody titres after the first vaccine injection. This latter dose had apparently no influence on the regulatory T cell circuits, as opposed to the other doses under study.
Related Publications
M Amadori, and
I L Archetti, and
C Berneri, and
E Lodetti, and
M Salvalai, and
P Cordioli, and
S Callegari
January 1988,
Voprosy virusologii,
M Amadori, and
I L Archetti, and
C Berneri, and
E Lodetti, and
M Salvalai, and
P Cordioli, and
S Callegari
January 1977,
Developments in biological standardization,
M Amadori, and
I L Archetti, and
C Berneri, and
E Lodetti, and
M Salvalai, and
P Cordioli, and
S Callegari
January 1975,
Journal of clinical microbiology,
M Amadori, and
I L Archetti, and
C Berneri, and
E Lodetti, and
M Salvalai, and
P Cordioli, and
S Callegari
June 2019,
Virologica Sinica,
M Amadori, and
I L Archetti, and
C Berneri, and
E Lodetti, and
M Salvalai, and
P Cordioli, and
S Callegari
January 1982,
Comptes rendus des seances de la Societe de biologie et de ses filiales,
M Amadori, and
I L Archetti, and
C Berneri, and
E Lodetti, and
M Salvalai, and
P Cordioli, and
S Callegari
January 1985,
General pharmacology,
M Amadori, and
I L Archetti, and
C Berneri, and
E Lodetti, and
M Salvalai, and
P Cordioli, and
S Callegari
January 1981,
Methods in enzymology,
M Amadori, and
I L Archetti, and
C Berneri, and
E Lodetti, and
M Salvalai, and
P Cordioli, and
S Callegari
January 1978,
The Journal of general virology,
M Amadori, and
I L Archetti, and
C Berneri, and
E Lodetti, and
M Salvalai, and
P Cordioli, and
S Callegari
July 1982,
Applied biochemistry and biotechnology,
M Amadori, and
I L Archetti, and
C Berneri, and
E Lodetti, and
M Salvalai, and
P Cordioli, and
S Callegari
October 1990,
Hepatology (Baltimore, Md.),
